Replies to post #203856 on Innovation Pharmaceuticals Inc (IPIX)

[DoubleJ23]

Leo has answered that question long ago. He made it crystal clear in the December 2015 shareholder meeting. The one rub with a shareholder meeting is: you have to be a shareholder to get that information.

[baytdr]

that's a conundrum. It's troubled me for some time. I'm sure it's a large factor in the current share price.

[MinnieM]

Regarding Brilacidin ph2b ABSSSI. The company told several of us at the 2015 Biotech Showcase that they don't want to partner with anyone until Brilacidin is in or done with phase III. They feel they'll get a substantially better deal at that time.




In Reply to 'scottsmith'
Agree. I’ve been saying, literally for years, that Leo should license by indication. I must say I received some blowback. But then here is the question — why the heck hasn’t our Uncle Leo licensed absssi??